Abstract
Four patients with acute myelogenous leukaemia (AML), who developed isolated thrombocytopenia after anti-leukaemic chemotherapy, were treated with cyclosporine A and showed significantly enhanced platelet recovery. All four patients demonstrated decreased bone marrow megakaryocytes without dysplastic features, absence of identifiable peripheral autoimmune platelet destruction or cytogenetic evidence of secondary myelodysplasia. The duration of response to cyclosporine A ranged from 6 days to 40 months. The mechanism of cyclosporine A-induced platelet recovery may include inhibition of negative modulators and induction of thrombopoietic cytokines mediated by bone marrow regulatory cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Matsumara, O., Kawashima, Y., Kato, S., Sanaka, T., Teraoka, S., Kawai, T., Honda, H., Fichinoue, S., Takahashi, K., Toma, H., Ota, K. and Sugino, N. (1988) Therapeutic effect of cyclosporine in thrombocytopenia associated with autoimmune disease.Transplantation Proceedings XX, (3), suppl. 4, 317–22.
Miesher, P.A., Favre, H. and Beris, P. (1991) Autoimmune myelodysplasias.Seminars in Hematology 28, 45, 322–30.
Kelsey, P.R., Schofield, K.P. and Geary, C.G. (1985) Refractory idiopathic thrombocytopenic purpura (ITF) treated with cyclosporine.British Journal of Haematology 60, 197–8.
Young, N.S. (1992) The problem of clonality in aplastic anemia: Dr Dameshek’s riddle, restated.Blood 79, (6), 1385–92.
Van Kamp, H., Van Imhoff, G. W., De Wolf, J.T. M., Smit, J., Halie, M.R. and Vellenga, E. (1995) The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria.British Journal of Haematology 89, 79–82.
Hill, W. and Landgraf, R. (1985) Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine. NewEngland Journal of Medicine,312, 1612 (letter).
Jacobs, P. Bone marrow failure: pathophysiology and management (1995)Disease-a-month XLI, 4, 203–89.
Nagasawa, T., Sakurai, T., Kashiwagi, H., Abe, T. (1986) Cell-mediated amegakaryocytic thrombocytopenia associated with systemiclupus erythematosus.Blood 67, 479–83.
Slater, L., Katz, J., Walter, B. and Armentrout, S. (1985) Aplastic anemia occurring as amegakaryocytic thrombocytopenia with and without an inhibitor of granulopoiesis.American Journal of Hematology 18, 251–4.
Berger, R., Majdic, O., Meingassner, J.G. and Knapp, W. (1982)In vitro effect of Cyclosporine A (CSA) on human hemopoietic cell lines,Immunopharmacology 5, 123–7.
Gordon, M.Y. and Singer, J.W. (1979) Selective effects of cyclosporine A on colony-forming lymphoid and myeloid cells in man.Nature 279, 433–4.
Hirao, A., Kawano, Y. and Takaue, Y. (1993) Effects of immunosuppressants FK 506, deoxypergualin, and cyclosporine A on immature human hamatopoiesis.Blood 81, (5), 1179–83.
Quesniaux, V.F.J. (1993) Immunosuppressants: Tools to investigate the physiological role of cytokines.BioEssays 15, (11), 731–9.
Cockerill, P.N., Shannon, M.F., Bert, A.G., Ryan, G.R. and Vadas, M.V. (1993) The granulocyte-macrophage colony-stimulating factor/ interleukin 3 locus is regulated by an inducible cyclosporine A-sensitive enhancer.Proceedings of National Academy of Science USA,90, 2466–70.
Walz, G., Zanker, B., Melton L., Suthatiran, M., Strom, T. (1990) Possible association of the immunosuppressive and B-cell lymphorna-promoting properties of cyclosporine.Transplantation 49, (1), 191–4.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Novik, Y., Oleksowicz, L. & Wiernik, P.H. Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia. Med Oncol 14, 43–46 (1997). https://doi.org/10.1007/BF02990945
Issue Date:
DOI: https://doi.org/10.1007/BF02990945